- Home
- ESPR vs JRS Comparison
ESPR vs JRS Comparison
Compare ESPR & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- JRS
- Stock Information
- Founded
- ESPR 2008
- JRS 2001
- Country
- ESPR United States
- JRS United States
- Employees
- ESPR N/A
- JRS N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- ESPR Health Care
- JRS Finance
- Exchange
- ESPR Nasdaq
- JRS Nasdaq
- Market Cap
- ESPR 220.0M
- JRS 224.5M
- IPO Year
- ESPR 2013
- JRS N/A
- Fundamental
- Price
- ESPR $1.40
- JRS $7.58
- Analyst Decision
- ESPR Buy
- JRS
- Analyst Count
- ESPR 6
- JRS 0
- Target Price
- ESPR $6.50
- JRS N/A
- AVG Volume (30 Days)
- ESPR 5.1M
- JRS 86.6K
- Earning Date
- ESPR 08-05-2025
- JRS 01-01-0001
- Dividend Yield
- ESPR N/A
- JRS 8.87%
- EPS Growth
- ESPR N/A
- JRS N/A
- EPS
- ESPR N/A
- JRS N/A
- Revenue
- ESPR $259,574,000.00
- JRS N/A
- Revenue This Year
- ESPR $6.10
- JRS N/A
- Revenue Next Year
- ESPR N/A
- JRS N/A
- P/E Ratio
- ESPR N/A
- JRS N/A
- Revenue Growth
- ESPR 12.99
- JRS N/A
- 52 Week Low
- ESPR $0.69
- JRS $5.95
- 52 Week High
- ESPR $3.94
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- ESPR 58.85
- JRS 34.42
- Support Level
- ESPR $1.13
- JRS $7.80
- Resistance Level
- ESPR $1.74
- JRS $7.88
- Average True Range (ATR)
- ESPR 0.17
- JRS 0.12
- MACD
- ESPR 0.01
- JRS -0.03
- Stochastic Oscillator
- ESPR 30.61
- JRS 9.30
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.